Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $607,013 | 157 | 71.3% |
| Travel and Lodging | $123,528 | 271 | 14.5% |
| Consulting Fee | $99,001 | 27 | 11.6% |
| Food and Beverage | $18,005 | 293 | 2.1% |
| Honoraria | $4,000 | 1 | 0.5% |
| Education | $71.23 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $240,671 | 172 | $0 (2024) |
| Clovis Oncology, Inc. | $186,481 | 171 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $105,657 | 92 | $0 (2024) |
| ABBVIE INC. | $73,279 | 57 | $0 (2024) |
| ImmunoGen, Inc. | $46,654 | 53 | $0 (2024) |
| Seagen Inc. | $44,808 | 28 | $0 (2023) |
| Merck Sharp & Dohme LLC | $31,336 | 38 | $0 (2024) |
| PFIZER INC. | $29,087 | 19 | $0 (2024) |
| TESARO, Inc. | $28,906 | 31 | $0 (2019) |
| Genmab U.S., Inc. | $20,066 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $150,952 | 128 | ABBVIE INC. ($69,063) |
| 2023 | $180,362 | 154 | GlaxoSmithKline, LLC. ($60,786) |
| 2022 | $108,377 | 83 | GlaxoSmithKline, LLC. ($68,413) |
| 2021 | $90,372 | 67 | GlaxoSmithKline, LLC. ($57,422) |
| 2020 | $59,911 | 51 | AstraZeneca Pharmaceuticals LP ($29,208) |
| 2019 | $105,241 | 120 | Clovis Oncology, Inc. ($45,078) |
| 2018 | $101,979 | 98 | Clovis Oncology, Inc. ($96,254) |
| 2017 | $54,424 | 50 | Clovis Oncology, Inc. ($36,433) |
All Payment Transactions
751 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Oncology | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $0.68 | General |
| Category: Oncology | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Travel and Lodging | Cash or cash equivalent | $102.51 | General |
| Category: Oncology | ||||||
| 12/05/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $25.68 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | ELAHERE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,654.00 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $473.31 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $338.96 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $136.52 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $132.68 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $49.00 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $36.31 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $14.94 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,920.00 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Oncology | ||||||
| 11/12/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Travel and Lodging | Cash or cash equivalent | $402.59 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Travel and Lodging | Cash or cash equivalent | $95.18 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,050.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 321 | 644 | $105,618 | $46,586 |
| 2022 | 6 | 333 | 651 | $109,651 | $47,618 |
| 2021 | 5 | 381 | 729 | $134,335 | $56,660 |
| 2020 | 6 | 372 | 802 | $169,997 | $48,308 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 150 | 436 | $75,892 | $33,134 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 134 | 170 | $19,680 | $8,325 | 42.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 26 | 26 | $7,250 | $3,720 | 51.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 12 | $2,796 | $1,407 | 50.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 151 | 428 | $77,496 | $33,006 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 118 | 147 | $17,388 | $7,194 | 41.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 26 | 26 | $6,844 | $3,797 | 55.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 15 | 17 | $3,591 | $2,048 | 57.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 21 | $3,192 | $1,214 | 38.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 12 | 12 | $1,140 | $358.31 | 31.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 184 | 519 | $93,152 | $38,672 | 41.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 45 | 45 | $14,195 | $6,920 | 48.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 113 | 121 | $14,236 | $6,222 | 43.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 21 | 26 | $7,432 | $2,857 | 38.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 18 | 18 | $5,320 | $1,989 | 37.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 167 | 501 | $103,673 | $30,529 | 29.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 131 | 160 | $25,284 | $6,183 | 24.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 16 | 56 | $12,490 | $3,307 | 26.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 26 | 26 | $9,005 | $3,299 | 36.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 13 | 37 | $11,636 | $3,210 | 27.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 19 | 22 | $7,909 | $1,780 | 22.5% |
About Dr. Robert Morris, MD
Dr. Robert Morris, MD is a Obstetrics & Gynecology healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659342756.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Morris, MD has received a total of $851,618 in payments from pharmaceutical and medical device companies, with $150,952 received in 2024. These payments were reported across 751 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($607,013).
As a Medicare-enrolled provider, Morris has provided services to 1,407 Medicare beneficiaries, totaling 2,826 services with total Medicare billing of $199,171. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Gynecologic Oncology
- Location Detroit, MI
- Active Since 01/28/2006
- Last Updated 05/18/2016
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1659342756
Products in Payments
- ZEJULA (Drug) $205,783
- Rubraca (Drug) $185,931
- LYNPARZA (Drug) $105,574
- TIVDAK (Biological) $73,894
- ELAHERE (Drug) $69,079
- JEMPERLI (Biological) $61,820
- Elahere (Biological) $46,638
- KEYTRUDA (Biological) $31,225
- Tivdak (Drug) $20,066
- DARZALEX (Biological) $12,775
- OVA1 (Device) $9,801
- YONDELIS (Drug) $6,956
- Lenvima (Drug) $6,119
- BENCHMARK SPECIAL STAINS WASH II (Device) $5,280
- Venclexta (Drug) $4,216
- PRECISETUMOR (Device) $124.92
- Avastin (Biological) $120.54
- FOUNDATIONONE (Device) $95.33
- ThinPrep Pap (Device) $77.41
- LYNPARZA (Biological) $64.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Detroit
Dr. David Eisenstein, M.d, M.D
Obstetrics & Gynecology — Payments: $351,113
Brent Davidson, M.d, M.D
Obstetrics & Gynecology — Payments: $188,377
Dr. Rabbie Hanna, M.d, M.D
Obstetrics & Gynecology — Payments: $156,083
Neil Simmerman, Md, MD
Obstetrics & Gynecology — Payments: $26,716
Dr. Ira Winer, Md, MD
Obstetrics & Gynecology — Payments: $25,218
Radhika Gogoi, Md, MD
Obstetrics & Gynecology — Payments: $11,891